122 related articles for article (PubMed ID: 2252123)
21. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
Sommer BG; Henry ML; Ferguson RM
Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
[No Abstract] [Full Text] [Related]
22. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone.
Halloran P; Ludwin D; Bear R; Aprile M; McQuarrie B; Poole R; White N
Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454
[No Abstract] [Full Text] [Related]
23. Renal transplantation at Hartford Hospital: results of combined and flexible immunosuppression.
Schweizer RT; Bow L; Roper L; Hull D; Bartus SA
Clin Transpl; 1988; ():147-58. PubMed ID: 3154467
[TBL] [Abstract][Full Text] [Related]
24. Low-dose cyclosporine, ALG, and steroids in first cadaveric renal transplants.
Griño JM; Castelao AM; Sabate I; Mestre M; Gil-Vernet S; Andres E; Sabater R; Alsina J
Transplant Proc; 1987 Oct; 19(5):3674-6. PubMed ID: 3313887
[No Abstract] [Full Text] [Related]
25. Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression.
Gaston RS; Hudson SL; Deierhoi MH; Barber WH; Laskow DA; Julian BA; Curtis JJ; Barger BO; Shroyer TW; Diethelm AG
Transplantation; 1992 Jan; 53(1):103-9. PubMed ID: 1733054
[TBL] [Abstract][Full Text] [Related]
26. Comparison of antithymocyte globulin antirejection treatment in renal transplant patients with either cyclosporine or azathioprine as basic immunosuppression.
Hoitsma AJ; Wetzels JF; Berden JH; Koene RA
Transplant Proc; 1987 Oct; 19(5):3589-91. PubMed ID: 3313864
[No Abstract] [Full Text] [Related]
27. A single center experience with "low-dose" cyclosporine in cadaveric renal transplantation.
Fries D; Hiesse C; Charpentier B; Lantz O; Bensadoun H; Benoit G
Clin Transpl; 1988; ():115-29. PubMed ID: 3154465
[No Abstract] [Full Text] [Related]
28. The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation.
First MR; Alexander JW; Wadhwa N; Penn I; Munda R; Fidler JP; Weiskittel P
Transplant Proc; 1986 Apr; 18(2 Suppl 1):132-5. PubMed ID: 3515680
[No Abstract] [Full Text] [Related]
29. Hyperuricemia after renal transplantation.
Gores PF; Fryd DS; Sutherland DE; Najarian JS; Simmons RL
Am J Surg; 1988 Nov; 156(5):397-400. PubMed ID: 3056057
[TBL] [Abstract][Full Text] [Related]
30. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
Feduska NJ; Melzer J; Amend WJ; Vincenti F; Tomlanovich S; Salvatierra O
Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681
[No Abstract] [Full Text] [Related]
31. Early and late effects of two immunosuppressive drug protocols on recipients of renal allografts: results of the Minnesota randomized trial comparing cyclosporine versus antilymphocyte globulin-azathioprine.
Canafax DM; Simmons RL; Sutherland DE; Fryd DS; Strand MH; Ascher NL; Payne WD; Najarian JS
Transplant Proc; 1986 Apr; 18(2 Suppl 1):192-6. PubMed ID: 3515687
[No Abstract] [Full Text] [Related]
32. A controlled trial of antihuman lymphocyte globulin (Behring) in cadaveric renal transplantation: improvement in graft and patient survival at one year using a high-dose regimen.
Groth CG; Berg B; Collste H; Lundgren G; Magnusson G; Ringdén O; Pieper R
Scand J Urol Nephrol Suppl; 1977; (42):83-5. PubMed ID: 356230
[TBL] [Abstract][Full Text] [Related]
33. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Guttmann RD; Flemming C
Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
[TBL] [Abstract][Full Text] [Related]
34. A randomized trial comparing double-drug and triple-drug therapy in primary cadaveric renal transplants.
Brinker KR; Dickerman RM; Gonwa TA; Hull AR; Langley JW; Long DL; Nesser DA; Trevino G; Velez RL; Vergne-Marini PJ
Transplantation; 1990 Jul; 50(1):43-9. PubMed ID: 2368149
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary infections. The Minnesota randomized prospective trial of cyclosporine vs azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Hesse UJ; Fryd DS; Chatterjee SN; Simmons RL; Sutherland DE; Najarian JS
Arch Surg; 1986 Sep; 121(9):1056-60. PubMed ID: 3527111
[TBL] [Abstract][Full Text] [Related]
36. Infectious complications with the use of cyclosporine versus azathioprine after cadaveric kidney transplantation.
Shaffer D; Hammer SM; Monaco AP
Am J Surg; 1987 Apr; 153(4):381-6. PubMed ID: 3105340
[TBL] [Abstract][Full Text] [Related]
37. Effect of sequential Minnesota-antilymphocyte globulin and cyclosporine therapy in primary cadaveric renal transplant recipients with delayed graft function.
Venkat KK; Kupin W; Oh HK
Transplant Proc; 1989 Feb; 21(1 Pt 2):1544-5. PubMed ID: 2652499
[No Abstract] [Full Text] [Related]
38. Pancreas transplantation with pancreaticocystostomy and quadruple immunosuppression.
Sollinger HW; Stratta RJ; Kalayoglu M; Pirsch JD; Belzer FO
Surgery; 1987 Oct; 102(4):674-9. PubMed ID: 3310299
[TBL] [Abstract][Full Text] [Related]
39. Benefits of quadruple immunosuppressive therapy in recipients of living related donor kidneys. A review of 855 operations.
Diethelm AG; Laskow DA; Hudson SL; Deierhoi MH; Barber WH; Barger BO; Julian BA; Gaston RS; Curtis JJ
Ann Surg; 1992 Jun; 215(6):606-16; discussion 616-7. PubMed ID: 1632682
[TBL] [Abstract][Full Text] [Related]
40. Optimal results in cadaver-donor renal transplantation using prophylactic ALG, cyclosporine, and prednisone.
Hiesse C; Fries D; Charpentier B; Neyrat N; Rieu P; Cantarovich M; Lantz O; Bellamy J; Benoit G
Transplant Proc; 1987 Oct; 19(5):3670-1. PubMed ID: 3313885
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
